An Efficacy and Safety Study of DFL24498 in the Treatment of AKC

NCT07395232 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
138
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Dompé Farmaceutici S.p.A